Arkolith/Insider Trading/BIAF/Form 4

Girgenti Steven

DirectorbioAffinity Technologies, Inc. (BIAF) · full profile →Form 4 · filed Apr 24, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 3, 2024Option exercise(M)65K$1.16$75K1.1M
Apr 3, 2024Tax withholding(F)33K$2.24$75K1.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 3, 2024Option exercise(M)65K—$00

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-015789) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML